Terug
Dagbereik
€ 32,50
€ 37,69
52-Weeksbereik
€ 32,50
€ 46,64
Volume
1.000
50D / 200D Gem.
€ 35,83
/
€ 38,53
Vorige Slotkoers
€ 37,69
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 8,3 | 0,4 |
| P/B | 0,7 | 2,9 |
| ROE % | 8,2 | 3,8 |
| Net Margin % | 1,8 | 3,9 |
| Rev Growth 5Y % | 7,5 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
24 B | 0 |
| FY2026 |
€ 0,00
€ 0,00 – € 0,00
|
22 B | 0 |
Belangrijkste Punten
Revenue grew 7,51% annually over 5 years — modest growth
Earnings declined -21,93% over the past year
Generating 396,38M in free cash flow
P/E of 8,34 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 15,85%
Cash machine — converts 171,11% of earnings into free cash flow
Groei
Revenue Growth (5Y)
7,51%
Revenue (1Y)-8,34%
Earnings (1Y)-21,93%
FCF Growth (3Y)11,49%
Kwaliteit
Return on Equity
8,23%
ROIC7,28%
Net Margin1,75%
Op. Margin3,45%
Veiligheid
Debt / Equity
0,59
Current Ratio1,18
Interest Coverage4,73
Waardering
P/E Ratio
8,34
P/B Ratio0,65
EV/EBITDA7,64
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -8,34% | Revenue Growth (3Y) | -0,41% |
| Earnings Growth (1Y) | -21,93% | Earnings Growth (3Y) | -8,34% |
| Revenue Growth (5Y) | 7,51% | Earnings Growth (5Y) | 3,86% |
| Profitability | |||
| Revenue (TTM) | 13,21B | Net Income (TTM) | 231,66M |
| ROE | 8,23% | ROA | 2,96% |
| Gross Margin | 13,35% | Operating Margin | 3,45% |
| Net Margin | 1,75% | Free Cash Flow (TTM) | 396,38M |
| ROIC | 7,28% | FCF Growth (3Y) | 11,49% |
| Safety | |||
| Debt / Equity | 0,59 | Current Ratio | 1,18 |
| Interest Coverage | 4,73 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 8,34 | P/B Ratio | 0,65 |
| P/S Ratio | 0,15 | PEG Ratio | -0,62 |
| EV/EBITDA | 7,64 | Dividend Yield | 0,04% |
| Market Cap | 1,93B | Enterprise Value | 3,48B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 13,21B | 14,41B | 13,32B | 11,90B | 9,89B |
| Net Income | 231,66M | 296,71M | 275,74M | 224,64M | 199,09M |
| EPS (Diluted) | 4,70 | 6,18 | 5,78 | 5,08 | 4,86 |
| Gross Profit | 1,76B | 1,78B | 1,70B | 1,38B | 1,07B |
| Operating Income | 455,58M | 527,24M | 499,00M | 250,73M | 317,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 7,84B | 7,37B | 7,01B | 6,95B | 4,24B |
| Total Liabilities | 4,90B | 4,73B | 4,50B | 4,56B | 2,73B |
| Shareholders' Equity | 2,95B | 2,68B | 2,65B | 1,56B | 1,52B |
| Total Debt | 1,75B | 1,80B | 1,40B | 1,83B | 730,98M |
| Cash & Equivalents | 198,40M | 236,98M | 230,59M | 573,58M | 181,53M |
| Current Assets | 3,32B | 3,26B | 3,27B | 2,10B | 2,28B |
| Current Liabilities | 2,82B | 3,41B | 2,89B | 1,73B | 2,02B |